3
Clinical Trials associated with ACYW135 meningococcal polysaccharide conjugate vaccine(NPO Petrovax) / Not yet recruitingPhase 3 Simple Blinded Multicenter Randomized Comparative Study to Assess Immunogenicity, Reactogenicity and Safety of the Drug GNG-DE
Assessment of immunogenicity, reactogenicity and safety of GNG-DE in comparison with the reference drug
A phase III clinical study to evaluate the immunogenicity and safety of Groups ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in healthy subjects aged 2 to 6 years old, 7 to 17 years old and 18 to 55 years old
Start Date16 Apr 2022 |
Sponsor / Collaborator- |
A phase III clinical study to evaluate the immunogenicity and safety of Groups ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in healthy subjects aged 6 to 23 months
Start Date30 Mar 2022 |
Sponsor / Collaborator- |
100 Clinical Results associated with ACYW135 meningococcal polysaccharide conjugate vaccine(NPO Petrovax)
100 Translational Medicine associated with ACYW135 meningococcal polysaccharide conjugate vaccine(NPO Petrovax)
100 Patents (Medical) associated with ACYW135 meningococcal polysaccharide conjugate vaccine(NPO Petrovax)
100 Deals associated with ACYW135 meningococcal polysaccharide conjugate vaccine(NPO Petrovax)